EDISON, N.J.—Carotech Inc., a GMP (good manufacturing practice)-certified tocotrienol producer, announced the Malaysian Palm Oil Board (MPOB) will hold its inaugural international conference on “Tocotrienols and Chronic Diseases” from July 29 to 30 at Wynn Resort, Las Vegas.
The two-day international conference gathers professors, academics, research and regulatory experts that present latest research updates, insights and new potentials of palm tocotrienol complex. It will highlight the novel benefits of palm tocotrienol complex such as neuroprotection against stroke-induced injuries, cardioprotection, skin nutrition (acceleration of wound healing and reduction in scarring), anti-inflammatory action, anti-cancers (prostate, breast, colon, etc.), protection against radiation injuries, nutrition, absorption/pharmacokinetic and bioavailability.
The MPOB’s decision to organize the conference came in conjunction with the news that palm tocotrienol complex received the final notification of no objection for GRAS (generally recognized as safe) from FDA in April 2010. Carotech has been actively involved in the process of GRAS application together with MPOB since 2008.
The significance of palm tocotrienol complex being GRAS approved means application of palm tocotrienol complex ingredient such as Tocomin® (Carotech Inc.) is now extended to everyday food and beverage products such as margarine and spreads, bakery products, functional beverages and more.
“This inaugural event is a “must attend” if you have been following tocotrienol’s studies that we regularly post on our Web sites, said WH Leong, vice president, Carotech Inc.. “We thank MPOB for inviting us to be a part of the Conference. We are proud to contribute to this scientific conference specifically on tocotrienols.”
